Camp4 Therapeutics Corporation · NASDAQ:CAMP
Vivo Opportunity Fund Holdings, L.P. reported a 7.60% stake in Camp4 Therapeutics Corporation (Schedule 13G)
Event Sep 11, 2025 · Filed Sep 17, 2025
Vivo Opportunity Fund Holdings, L.P. reported a 7.60% stake in Camp4 Therapeutics Corporation, 3,561,793 shares, as a passive investor on Sep 11, 2025. Filed Sep 17, 2025 (Schedule 13G).
- Stake
- 7.60%
- Shares
- 3,561,793
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 7.60% | 3,561,793 |
| Vivo Opportunity, LLC | 7.60% | 3,561,793 |
| Vivo Opportunity Cayman Fund, L.P. | 0.80% | 359,775 |
| Vivo Opportunity Cayman, LLC | 0.80% | 359,775 |
Source
Related
- Camp4 Therapeutics Corporation
- Vivo Opportunity, LLC
- Camp4 Therapeutics Corporation shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · Feb 13, 2026
- Form 4 · Gold Kelly · Sep 2, 2026
- Form 4 · Schwab Andrew J. · Aug 31, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 31, 2026
- Form 4 · Schwab Andrew J. · Aug 26, 2026
- Form 4 · Schwab Andrew J. · Aug 21, 2026